drugset / Trial / NCT00592943
PET Study Examining the Dopaminergic Activity of Armodafinil in Adults
RandomizedParallel-groupOpen-label
Summary
The specific aims of this study are 1) to document the Dopamine Transporter (DAT) receptor occupancy of armodafinil using positron emission tomography (PET) scanning with C-11 altropane as the ligand and 2) to document the increased intrasynaptic dopamine produced by armodafinil using PET scanning with C-11 raclopride as the ligand. We hypothesize that DAT occupancy will be low with armodafinil; less than the DAT occupancy produced by therapeutic doses of methylphenidate. We also hypothesize that increases in intrasynaptic dopamine will be relatively low with armodafinil.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Armodafinil | Small molecule | 100 mg | Oral |
| Comparator | Armodafinil | Small molecule | 250 mg | Oral |
Indications
No indication recorded.